Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
IBRO Neuroscience Reports
|
February 3, 2025
Multimodal magnetic resonance imaging studies on non-motor symptoms of Parkinson's disease
Weimin Qi, Xiaoyan Niu, Xiuping Zhan, et al.
Future Oncology (London, England)
|
December 17, 2020
Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component
Jianxia Li, Liu Yang, Fan Bai, et al.
Frontiers in Molecular Biosciences
|
December 13, 2021
Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients
Jikun Feng, Jianxia Li, Xinjian Huang, et al.
Cancer Letters
|
June 26, 2026
VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3<sup>+</sup> macrophages and enhancing antitumor immunity
Fan Bai, Ge Qin, Jianxia Li, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
October 1, 2018
[Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer]
Yue Cai, Ru Deng, Huabin Hu, et al.
Gerontology
|
December 4, 2025
Prevalence and Factors Associated with Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis
Leixia Wang, Jianqian Chao, Na Zhang, et al.
Oncotargets and Therapy
|
September 24, 2025
Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study
Chenchen Li, Peicong Cai, Hengda Zeng, et al.
Diseases of the Colon and Rectum
|
July 14, 2022
Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy
Jianwei Zhang, Jianxia Li, Meijin Huang, et al.
Molecular Medicine (Cambridge, Mass.)
|
January 19, 2024
Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy
Ge Qin, Fan Bai, Huabin Hu, et al.
Clinical Colorectal Cancer
|
December 29, 2021
mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis
Miaomiao Ding, Jianwei Zhang, Huabin Hu, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
IBRO Neuroscience Reports
|
February 3, 2025
Multimodal magnetic resonance imaging studies on non-motor symptoms of Parkinson's disease
Weimin Qi, Xiaoyan Niu, Xiuping Zhan, et al.
Future Oncology (London, England)
|
December 17, 2020
Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component
Jianxia Li, Liu Yang, Fan Bai, et al.
Frontiers in Molecular Biosciences
|
December 13, 2021
Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients
Jikun Feng, Jianxia Li, Xinjian Huang, et al.
Cancer Letters
|
June 26, 2026
VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3<sup>+</sup> macrophages and enhancing antitumor immunity
Fan Bai, Ge Qin, Jianxia Li, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
October 1, 2018
[Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer]
Yue Cai, Ru Deng, Huabin Hu, et al.
Gerontology
|
December 4, 2025
Prevalence and Factors Associated with Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis
Leixia Wang, Jianqian Chao, Na Zhang, et al.
Oncotargets and Therapy
|
September 24, 2025
Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study
Chenchen Li, Peicong Cai, Hengda Zeng, et al.
Diseases of the Colon and Rectum
|
July 14, 2022
Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy
Jianwei Zhang, Jianxia Li, Meijin Huang, et al.
Molecular Medicine (Cambridge, Mass.)
|
January 19, 2024
Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy
Ge Qin, Fan Bai, Huabin Hu, et al.
Clinical Colorectal Cancer
|
December 29, 2021
mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis
Miaomiao Ding, Jianwei Zhang, Huabin Hu, et al.
Page
of 5